Asia Pacific Pharmaceutical Drug Delivery Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Country Analysis By  Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery); Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory. Diseases, Central Nervous System Disorders, Autoimmune Diseases, and Other Diseases); End User (Hospitals, Home Care Settings, ASC/Clinics, Other End Users); and Country

No. of Pages: 146    |    Report Code: TIPRE00011593    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Pharmaceutical Drug Delivery Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Pharmaceutical Drug Delivery Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific Pharmaceutical Drug Delivery Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing Prevalence of Chronic Diseases and Infectious Diseases
  • 5.1.2 Increasing Demand for Non-Invasive Drug Delivery
5.2 Market Opportunities
  • 5.2.1 Focus on Improving Patient Compliance
5.3 Future Trends
  • 5.3.1 N/A
5.4 Impact of Drivers and Restraints

6. Asia Pacific Pharmaceutical Drug Delivery Market Regional Analysis

6.1 Asia Pacific Pharmaceutical Drug Delivery Market Overview
6.2 Asia Pacific Pharmaceutical Drug Delivery Market Revenue 2017-2027 (US$ Million)
6.3 Asia Pacific Pharmaceutical Drug Delivery Market Forecast Analysis

7. Asia Pacific Pharmaceutical Drug Delivery Market Analysis – by Route of Administration

7.1 Oral Drug Delivery
  • 7.1.1 Overview
  • 7.1.2 Oral Drug Delivery: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Injectable Drug Delivery
  • 7.2.1 Overview
  • 7.2.2 Injectable Drug Delivery: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Topical Drug Delivery
  • 7.3.1 Overview
  • 7.3.2 Topical Drug Delivery: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Ocular Drug Delivery
  • 7.4.1 Overview
  • 7.4.2 Ocular Drug Delivery: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Pulmonary Drug Delivery
  • 7.5.1 Overview
  • 7.5.2 Pulmonary Drug Delivery: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Nasal Drug Delivery
  • 7.6.1 Overview
  • 7.6.2 Nasal Drug Delivery: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Transmucosal Drug Delivery
  • 7.7.1 Overview
  • 7.7.2 Transmucosal Drug Delivery: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Implantable Drug Delivery
  • 7.8.1 Overview
  • 7.8.2 Implantable Drug Delivery: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Pharmaceutical Drug Delivery Market Analysis – by Application

8.1 Infectious Diseases
  • 8.1.1 Overview
  • 8.1.2 Infectious Diseases: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Cancer
  • 8.2.1 Overview
  • 8.2.2 Cancer: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Cardiovascular Diseases
  • 8.3.1 Overview
  • 8.3.2 Cardiovascular Diseases: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Diabetes
  • 8.4.1 Overview
  • 8.4.2 Diabetes: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Respiratory Diseases
  • 8.5.1 Overview
  • 8.5.2 Respiratory Diseases: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Central Nervous System Disorders
  • 8.6.1 Overview
  • 8.6.2 Central Nervous System Disorders: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Autoimmune Diseases
  • 8.7.1 Overview
  • 8.7.2 Autoimmune Diseases: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.8 Other Diseases
  • 8.8.1 Overview
  • 8.8.2 Other Diseases: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9. Asia Pacific Pharmaceutical Drug Delivery Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Other Diseases: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Home Care Settings
  • 9.2.1 Overview
  • 9.2.2 Other Diseases: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.3 ASC/Clinics
  • 9.3.1 Overview
  • 9.3.2 Other Diseases: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Other End Users
  • 9.4.1 Overview
  • 9.4.2 Other Diseases: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10. Asia Pacific Pharmaceutical Drug Delivery Market – Asia-Pacific Analysis

10.1 Asia-Pacific
  • 10.1.1 Asia Pacific Pharmaceutical Drug Delivery Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 10.1.1.1 Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 China: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 China: Asia Pacific Pharmaceutical Drug Delivery Market Breakdown, by Route of Administration
    • 10.1.1.1.2 China: Asia Pacific Pharmaceutical Drug Delivery Market Breakdown, by Application
    • 10.1.1.1.3 China: Asia Pacific Pharmaceutical Drug Delivery Market Breakdown, by End User
  • 10.1.1.2 India: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 India: Asia Pacific Pharmaceutical Drug Delivery Market Breakdown, by Route of Administration
    • 10.1.1.2.2 India: Asia Pacific Pharmaceutical Drug Delivery Market Breakdown, by Application
    • 10.1.1.2.3 India: Asia Pacific Pharmaceutical Drug Delivery Market Breakdown, by End User
  • 10.1.1.3 Japan: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 Japan: Asia Pacific Pharmaceutical Drug Delivery Market Breakdown, by Route of Administration
    • 10.1.1.3.2 Japan: Asia Pacific Pharmaceutical Drug Delivery Market Breakdown, by Application
    • 10.1.1.3.3 Japan: Asia Pacific Pharmaceutical Drug Delivery Market Breakdown, by End User
  • 10.1.1.4 Australia: Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.4.1 Australia: Asia Pacific Pharmaceutical Drug Delivery Market Breakdown, by Route of Administration
    • 10.1.1.4.2 Australia: Asia Pacific Pharmaceutical Drug Delivery Market Breakdown, by Application
    • 10.1.1.4.3 Australia: Asia Pacific Pharmaceutical Drug Delivery Market Breakdown, by End User
  • 10.1.1.5 Rest of Asia-Pacific : Asia Pacific Pharmaceutical Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Pharmaceutical Drug Delivery Market Breakdown, by Route of Administration
    • 10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Pharmaceutical Drug Delivery Market Breakdown, by Application
    • 10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Pharmaceutical Drug Delivery Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Asia Pacific Pharmaceutical Drug Delivery Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 3M
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Antares Pharma
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Bayer AG
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 BD
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 GlaxoSmithKline plc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - A Market

The List of Companies - Asia Pacific Pharmaceutical Drug Delivery Market

  1. 3M
  2. Antares Pharma
  3. Bayer AG
  4. BD
  5. GlaxoSmithKline plc

 

asia-pacific-pharmaceutical-drug-delivery-market